Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Onsdag 15 Januari | 05:38:07 Europe / Stockholm

Svenska | English

Penser Access & Future by Carnegie

Prenumeration

2024-09-04 14:50:00

I en intervju med Tobias Agervald, vd på Guard Therapeutics, får vi höra mer om bolagets fas IIb-studie med RMC-035 som precis initierats.

Se intervjun på Penser Play: https://youtu.be/rP_XacWmzN8
Detta är en betald analys från Carnegie Investment Bank. Läs mer på: Commissioned Research - Carnegie